Skip to main content
OpenTrials
Completed

NCT Number: NCT02066480

Improved Screening for Osteoporosis

Osteoporosis is a disease characterized by skeletal fragility due to decreased bone mass and deterioration of bone microarchitecture , leading to increased fracture risk for low trauma, such as spinal fractures or femoral neck .

It is estimated that 3 million people are living in France , particularly women , with an incidence that increases with age .

This disease is a major public health issue in terms of morbidity and mortality , costs and risk of recurrence (after a first fracture episode) , including risk factors are identified.

However, although bone densitometry is a reliable diagnostic tool and preventive treatments are at our disposal, screening for osteoporosis is still insufficient .

The objective of our study is to improve the detection of osteoporosis in Hospital Departmental Vendee , using a simple questionnaire seeking risk factors followed by bone densitometry or if risk factors are found. Based on the results , the patient will be sent in rheumatology consultation for implementation of treatment if necessary .

Therefore included women hospitalized in medical services , gynecology, surgery and orthopedics Hospital Departmental Vendee , aged 50 to 80 years. Will not be included women who could answer a simple questionnaire and those previously treated for osteoporosis or have already received a bone density there is less than 3 years old .

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–80 year

Sex eligibility

Female

Study type

Observational

Primary location

Centre hospitalier départemental Vendée

La Roche-sur-Yon, 85925, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women between 50 and 80 years
  • Hospitalized
  • In health services, orthopedics, gynecology, surgery
  • Able to respond to an easy questionnaire
  • Able to give their agreement to participate in the study

Exclusion criteria

  • Patients with dementia
  • Patients can not express
  • Patients at end of life
  • Patients previously treated for osteoporosis or recent densitometry (BMD) <3 years
  • Patients could not be seen in time by the nurse during their hospitalization
  • Patients receiving a measure of legal protection

Treatment and study plan

Primary outcomes

  1. Number of patients screened at risk for osteoporosis

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Departemental Vendee

Other

Registry information

Official study title

Improved Screening for Osteoporosis in Women Between 50 and 80 Years Hospitalized in Hospital Departmental Vendee

Acronym: ADOV

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Feb 19, 2014
Registry last updated
Nov 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.